Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)

Despite low rates of bacterial co-infections, most COVID-19 patients receive antibiotic therapy. We hypothesized that patients with positive pneumococcal urinary antigens (PUAs) would benefit from antibiotic therapy in terms of clinical outcomes (death, ICU admission, and length of stay). The San Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Valsecchi, Pietro, Colaneri, Marta, Zuccaro, Valentina, Asperges, Erika, Costanzo, Filippo, Mariani, Bianca, Roda, Silvia, Minucci, Rita, Bertuccio, Francesco, Fraolini, Elia, Bosio, Matteo, Tirelli, Claudio, Oggionni, Tiberio, Corsico, Angelo, Bruno, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401143/
https://www.ncbi.nlm.nih.gov/pubmed/34442406
http://dx.doi.org/10.3390/jpm11080762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401143/
https://www.ncbi.nlm.nih.gov/pubmed/34442406
http://dx.doi.org/10.3390/jpm11080762

Ejemplares similares